The report will be delivered in 2-3 business days.

Vaccines Global Market Report 2019

Starting Price : $ 4000.00 | Pages : 200 | Published : December 2019 | SKU CODE : 7184 | Format :


The vaccines market consists of sales of vaccines and related services. This industry includes establishments that produce anti-infective vaccines, autoimmunity vaccines and vaccines for cancer and other diseases. Vaccines create antibody-antigen reaction that helps in attaining resistance to the disease causing organism. Vaccines include recombinant vaccines, conjugate vaccines, live attenuated vaccines, inactivated vaccines, toxoid vaccines and others.

The global vaccines market was valued at about $29.64 billion in 2018 and is expected to grow to $43.79 billion at a CAGR of 10.3% through 2022.

Rising awareness on immunization and vaccination benefits in emerging markets is consistently driving the global vaccines market growth. World Health Organization (WHO) is taking initiatives to increase awareness of immunization through global vaccine action plan (GVAP) and global Immunization vision and strategy (GIVS). They aim to strengthen routine immunization, control morbidity and mortality from vaccine preventable diseases and help countries to immunize more people with a greater range of vaccines. The Organization accomplishes this work through its biological programme, the WHO Collaborating Centers, and the WHO Expert Committee on Biological Standardization (ECBS). In 2017, according to WHO statistics,85% of the total infants across the globe, (116.2 million) received 3 doses of diphtheria-tetanus-pertussis vaccine in order to increase immunization and protect them against infectious diseases that can cause serious illness and disability. Furthermore, 123 countries reached 90% coverage of DTP3 vaccine in 2017.

The vaccines market growth is limited due to severe shortage of skilled healthcare professionals for developing biologics drugs which requires specialized skillsets. These skillsets are limited to some research organizations and medical equipment companies in the USA and Europe, this is expected to be a major restraint on the market. As of 2018, 40% of the biopharma industry was facing difficulties in hiring for process development staff due to shortage of talent. This shortage also led to rise in competition and salaries for the limited talent pool available for biologics talent, thereby further limiting growth of the market.

The vaccines market has been witnessing multiple strategic initiatives and mergers and acquisitions in the recent years. Top companies in the market are strategically acquiring start-ups and mid-sized companies to broaden products and services. For instance, in February 2019, Bharat Biotech acquired Chiron Behring Vaccines, a clinical biotechnology company, one of the leading manufacturers of rabies vaccines across the globe. Similarly, in 2017, Takeda Pharmaceutical acquired ARIAD Pharmaceuticals for approximately $5.2 billion, and Sanofi acquired Protein Sciences for $650 million. Companies in the industry are increasingly realigning their portfolios and pursuing profitable inorganic growth opportunities. Additionally, M&A interest is also being fueled by stronger corporate balance sheets, liquid debt markets, and continued favorable interest rates globally.

The Food and Drug Administration (FDA) is the National Regulatory Authority (NRA) in the United States responsible for assuring quality, safety, and effectiveness of all vaccines for human use. Center for Biologics Evaluation and Research (CBER) within the US FDA is responsible for regulating vaccines market. Governments across the world are encouraging the research and development of biologics in order to develop more targeted therapies and vaccines for various diseases. In May 2014, the US’s FDA announced a fast-track initiative to review its drugs and biologics policy to speed the availability of therapies to patients with serious conditions, orphan drugs for rare disease, while preserving the safety and efficacy standards. In 2016, FDA also removed a rule (Section 610.21 of the FDA code) which specified minimal potency limits for certain antibodies and antigens. . In addition, FDA is also updating regulations (Section 610.53 of FDA code) regarding storage periods and storage conditions for biologics.

In October 2018, Emergent BioSolutions, a multinational specialty biopharmaceutical company, acquired PaxVax for $270 million. This acquisition would strengthen and expand Emergent BioSolution's product portfolio with PaxVax's typhoid vaccine Vivotif, cholera vaccine Vaxchora and additional clinical-stage vaccine used in the prevention of typhoid fever, cholera, chikungunya and other emerging infectious diseases. PaxVax is a company focused on developing, manufacturing, and commercializing specialty vaccines that protect against existing and emerging infectious diseases. PaxVax was founded in 2006 and is headquartered in Cayman Islands, a British Overseas Territory.

Major players in the market are AstraZeneca, Emergent Biosolutions , Glaxosmithkline , Merck , Pfizer 

    1. Executive Summary

    2. Vaccines  Market Characteristics

    3. Vaccines  Market Size And Growth

    3.1. Global Vaccines  Historic Market, 2014 - 2018, $ Billion

    3.1.1. Drivers Of The Market

    3.1.2. Restraints On The Market

    3.2. Global Vaccines  Forecast Market, 2018 - 2022F, 2025F, 2030F, $ Billion

    3.2.1. Drivers Of The Market

    3.2.2. Restraints On the Market

    4. Vaccines  Market Segmentation

    4.1. Global Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Anti-Infective Vaccines

    Autoimmunity

    Others (Cancer And Others)

    4.2. Global Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Conjugate Vaccines

    Inactivated and Subunit Vaccines

    Live Attenuated Vaccines

    Recombinant Vaccines

    Toxoid Vaccines

    4.3. Global Vaccines  Market, Segmentation By Route of Administration, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Intramuscular (IM)

    Subcutaneous (SC)

    Oral

    Others

    4.4. Global Vaccines  Market, Segmentation By Valance, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Monovalent

    Multivalent

    4.5. Global Vaccines  Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Institutional Sale

    Hospital Pharmacies

    Retail Pharmacies

    5. Vaccines  Market Regional And Country Analysis

    5.1. Global Vaccines  Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    5.2. Global Vaccines  Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    6. Asia-Pacific Vaccines  Market  

    6.1. Asia-Pacific Vaccines  Market Overview  

    6.2. Asia-Pacific Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    6.3. Asia-Pacific Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    7. China Vaccines  Market  

    7.1. China Vaccines  Market Overview  

    7.2. China Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F,$ Billion

    7.3. China Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F,$ Billion

    8. India Vaccines  Market  

    8.1. India Vaccines  Market Overview  

    8.2. India Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    8.3. India Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    9. Japan Vaccines  Market  

    9.1. Japan Vaccines  Market Overview  

    9.2. Japan Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    9.3. Japan Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    10. Australia Vaccines  Market  

    10.1. Australia Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    10.2. Australia Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    11. Indonesia Vaccines  Market  

    11.1. Indonesia Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    11.2. Indonesia Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    12. South Korea Vaccines  Market  

    12.1. South Korea Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    12.2. South Korea Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    13. Western Europe Vaccines  Market  

    13.1. Western Europe Vaccines  Market Overview

    13.2. Western Europe Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    13.3. Western Europe Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    14. UK Vaccines  Market  

    14.1. UK Vaccines  Market Overview

    14.2. UK Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    14.3. UK Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    15. Germany Vaccines  Market  

    15.1. Germany Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    15.2. Germany Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    16. France Vaccines  Market  

    16.4. France Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    16.5. France Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    17. Eastern Europe Vaccines  Market  

    17.1. Eastern Europe Vaccines  Market Overview

    17.2. Eastern Europe Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    17.3. Eastern Europe Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    18. Russia Vaccines  Market  

    18.1. Russia Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    18.2. Russia Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    19. North America Vaccines  Market  

    19.1. North America Vaccines  Market Overview

    19.2. North America Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    19.3. North America Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    20. USA Vaccines  Market  

    20.1. USA Vaccines  Market Overview

    20.2. USA Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    20.3. USA Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    21. South America Vaccines  Market  

    21.1. South America Vaccines  Market Overview

    21.2. South America Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    21.3. South America Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    22. Brazil Vaccines  Market  

    22.1. Brazil Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    22.2. Brazil Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    23. Middle East Vaccines  Market  

    23.1. Middle East Vaccines  Market Overview

    23.2. Middle East Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    23.3. Middle East Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    24. Africa Vaccines  Market  

    24.1. Africa Vaccines  Market Overview

    24.2. Africa Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    24.3. Africa Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    25. Vaccines  Market Competitive Landscape And Company Profiles

    25.1. Vaccines  Market Competitive Landscape

    25.2. Vaccines  Market Company Profiles

    25.2.1. AstraZeneca

    25.2.1.1. Overview

    25.2.1.2. Products and Services

    25.2.1.3. Strategy

    25.2.1.4. Financial Performance

    25.2.2. Emergent Biosolutions 

    25.2.2.1. Overview

    25.2.2.2. Products and Services

    25.2.2.3. Strategy

    25.2.2.4. Financial Performance

    25.2.3. Glaxosmithkline 

    25.2.3.1. Overview

    25.2.3.2. Products and Services

    25.2.3.3. Strategy

    25.2.3.4. Financial Performance

    25.2.4. Merck 

    25.2.4.1. Overview

    25.2.4.2. Products and Services

    25.2.4.3. Strategy

    25.2.4.4. Financial Performance

    25.2.5. Pfizer 

    25.2.5.1. Overview

    25.2.5.2. Products and Services

    25.2.5.3. Strategy

    25.2.5.4. Financial Performance

    26. Key Mergers And Acquisitions In The Vaccines  Market

    27. Vaccines  Market Trends And Strategies

    28. Product Pipeline Analysis

    29. Vaccines  Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Research Inquiries

    30.4. The Business Research Company

    30.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2014-2018, $ Billion
  • Table 2: Global Forecast Market Growth, 2014-2022F, 2025F, 2030F, $ Billion
  • Table 3: Global Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 4: Global Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 5: Global Vaccines  Market, Segmentation By Route of Administration, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 6: Global Vaccines  Market, Segmentation By Valance, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 7: Global Vaccines  Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 8: Global Vaccines  Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 9: Global Vaccines  Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 10: Asia-Pacific, Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 11: Asia-Pacific, Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 12: China, Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 13: China, Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 14: India, Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 15: India, Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 16: Japan, Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 17: Japan, Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 18: Australia, Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 19: Australia, Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 20: Indonesia, Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 21: Indonesia, Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 22: South Korea, Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 23: South Korea, Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 24: Western Europe, Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 25: Western Europe, Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 26: UK, Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 27: UK, Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 28: Germany, Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 29: Germany, Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 30: France, Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 31: France, Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 32: Eastern Europe, Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 33: Eastern Europe, Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 34: Russia, Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 35: Russia, Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 36: North America, Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 37: North America, Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 38: USA, Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 39: USA, Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 40: South America, Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 41: South America, Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 42: Brazil, Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 43: Brazil, Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 44: Middle East, Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 45: Middle East, Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 46: Africa, Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 47: Africa, Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 48: AstraZeneca Financial Performance
  • Table 49: Emergent Biosolutions  Financial Performance
  • Table 50: Glaxosmithkline  Financial Performance
  • Table 51: Merck  Financial Performance
  • Table 52: Pfizer  Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2014-2018, $ Billion
  • Figure 2: Global Forecast Market Growth, 2014-2022F, 2025F, 2030F, $ Billion
  • Figure 3: Global Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 4: Global Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 5: Global Vaccines  Market, Segmentation By Route of Administration, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 6: Global Vaccines  Market, Segmentation By Valance, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 7: Global Vaccines  Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 8: Global Vaccines  Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 9: Global Vaccines  Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 10: Asia-Pacific, Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 11: Asia-Pacific, Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 12: China, Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 13: China, Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 14: India, Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 15: India, Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 16: Japan, Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 17: Japan, Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 18: Australia, Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 19: Australia, Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 20: Indonesia, Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 21: Indonesia, Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 22: South Korea, Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 23: South Korea, Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 24: Western Europe, Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 25: Western Europe, Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 26: UK, Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 27: UK, Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 28: Germany, Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 29: Germany, Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 30: France, Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 31: France, Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 32: Eastern Europe, Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 33: Eastern Europe, Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 34: Russia, Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 35: Russia, Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 36: North America, Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 37: North America, Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 38: USA, Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 39: USA, Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 40: South America, Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 41: South America, Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 42: Brazil, Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 43: Brazil, Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 44: Middle East, Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 45: Middle East, Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 46: Africa, Vaccines  Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 47: Africa, Vaccines  Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 48: AstraZeneca Financial Performance
  • Figure 49: Emergent Biosolutions  Financial Performance
  • Figure 50: Glaxosmithkline  Financial Performance
  • Figure 51: Merck  Financial Performance
  • Figure 52: Pfizer  Financial Performance
Research And Development Initiatives Taken In The Anti-Infective Drugs Market
Research Initiatives And Funding And Demand For New Medicines For Drug-Resistant Infections In The Anti-Infective Drugs Industry
Global Biologics Market, Opportunities And Strategies Market | Characteristics, Forecast Size, Trends
Biologics Market By Types (Monoclonal Antibodies, Therapeutic Proteins And Vaccines), By Trends, By Regions and By Key Players - Global Forecast To 2021
View Report
Pharmaceutical Drugs Market By Segments (Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs) - Global Forecast To 2022
View Report
Cardiovascular Drugs Global Market Report 2019
View Report
Dermatology Drugs Global Market Report 2019
View Report
Gastrointestinal Drugs Global Market Report 2019
View Report
Hematology Drugs Global Market Report 2019
View Report
Metabolic Disorders Drugs Global Market Report 2019
View Report
Musculoskeletal Disorders Drugs Global Market Report 2019
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)